SAZ.DE - STADA Arzneimittel Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR

STADA Arzneimittel Aktiengesellschaft

Stadastrasse 2-18
Bad Vilbel 61118
49 6101 603 0

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees10,176

Key Executives

NameTitlePayExercisedYear Born
Dr. Claudio AlbrechtChairman of the Exec. Board & CEON/AN/A1959
Mr. Mark Burgess Keatley MBA, MA, MPhilCFO & Member of Exec. BoardN/AN/A1957
Dr. Barthold PieningChief Technical Operations Officer & Member of Exec. BoardN/AN/A1958
Ms. Leslie Isabelle IltgenVP of Investor RelationsN/AN/AN/A
Mr. Sebastian Kramer-BachExec. VP of Corp. CommunicationN/AN/A1975
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxone for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Pantoprazole for gastric ulcer/reflux. The Branded Products segment offers APO-Go a Parkinson's medicine; Grippostad a cold medicine; Aqualor for rhinitis/sore throat; Snup for rhinitis; and Vitaprost for prostate disease indications. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and consumers, doctors, pharmacies and pharmacy chains, hospitals, mail-order companies, buying groups, wholesalers, and other service providers in the health care market, as well as public or private health insurance organizations. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH.

Corporate Governance

STADA Arzneimittel Aktiengesellschaft’s ISS Governance QualityScore as of April 1, 2018 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.